We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Sciclone Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 128 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 129 → 0 (-129)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $394M → $0 (-$394M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 128

Holders
–
Holders Change
-129
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
128
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$82.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$33.3M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$32.3M
4
GP
GLG Partners
United Kingdom
-$29M
5
State Street
State Street
Massachusetts
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
LIA
101
LS Investment Advisors
Michigan
– -$154K -13,720 Closed
MSA
102
Mason Street Advisors
Wisconsin
– -$148K -13,219 Closed
VF
103
Virtu Financial
New York
– -$137K -12,243 Closed
O
104
OppenheimerFunds
New York
– -$129K -11,539 Closed
PIA
105
Piedmont Investment Advisors
North Carolina
– -$127K -11,368 Closed
SOADOR
106
State of Alaska Department of Revenue
Alaska
– -$114K -10,213 Closed
Fidelity Investments
107
Fidelity Investments
Massachusetts
– -$112K -10,003 Closed
NA
108
NewEdge Advisors
Louisiana
– -$111K -10,000 Closed
PI
109
PineBridge Investments
New York
– -$73K -6,477 Closed
Royal Bank of Canada
110
Royal Bank of Canada
Ontario, Canada
– -$63K -5,618 Closed
AIP
111
Ameritas Investment Partners
Nebraska
– -$50K -4,558 Closed
Zurich Cantonal Bank
112
Zurich Cantonal Bank
Switzerland
– -$47K -4,238 Closed
Bank of Montreal
113
Bank of Montreal
Ontario, Canada
– -$41K -3,609 Closed
US Bancorp
114
US Bancorp
Minnesota
– -$23K -2,018 Closed
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
– -$15K -1,380 Closed
Pacer Advisors
116
Pacer Advisors
Pennsylvania
– -$14K -1,209 Closed
PNC Financial Services Group
117
PNC Financial Services Group
Pennsylvania
– -$11K -1,007 Closed
WT
118
Whittier Trust
California
– -$11K -1,000 Closed
RA
119
Royce & Associates
New York
– -$8K -717 Closed
FMA
120
FNY Managed Accounts
New York
– -$6K -560 Closed
IA
121
IFP Advisors
Florida
– -$6K -500 Closed
Group One Trading
122
Group One Trading
Illinois
– -$3K -300 Closed
TRCT
123
Tower Research Capital (TRC)
New York
– -$3K -286 Closed
SPIA
124
Steward Partners Investment Advisory
New York
– -$2K -250 Closed
MAM
125
Meeder Asset Management
Ohio
– -$2K -150 Closed
2 3 4
5
6

SCLN Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q4 2017, worth a combined $0 — down 100% from $394M a quarter earlier.

Sellers outnumbered buyers: 128 funds closed out of SCLN and 0 opened new positions — a net loss of 128 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $82.1M sold.

  • 0 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q4 2017, down from 129 in Q3 2017.
  • Funds reported $0 of Sciclone Pharmaceuticals Inc stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Sciclone Pharmaceuticals Inc positions in Q4 2017 and 128 closed out, a net change of -128 holders.
  • The largest Sciclone Pharmaceuticals Inc seller in Q4 2017 was BlackRock, an estimated $82.1M sold.

Based on aggregated 13F filings for Q4 2017.